Santaularia Jeanie, Hou Wei, Perveen Ghazala, Welsh Ericka, Faseru Babalola
Kansas Department of Health and Environment, Bureau of Health Promotion, 1000 SW Jackson Suite 200, Topeka, 66619, Kansas, USA.
Department of Preventive Medicine and Public Health, University of Kansas Medical Center, 3901 Rainbow Boulevard, MS 1008, Kansas City, KS, 66160, USA.
BMC Public Health. 2016 Feb 24;16:185. doi: 10.1186/s12889-016-2884-5.
According to the Centers for Disease Control and Prevention, approximately 5-20% of people are affected by influenza annually, and influenza causes more than 200,000 hospitalizations each year. The purpose of this study is to estimate the prevalence of influenza vaccination among high risk adults in Kansas.
The 2013 Kansas BRFSS data (n = 20,712) were analyzed to assess the prevalence of receiving influenza vaccination among Kansas adults, overall and for selected demographic characteristics within the past 12 months. Crude and adjusted prevalence rate ratios were computed using univariate logistic regression models with influenza vaccination as the dependent variable and health conditions or high risk groups as the main independent variables; these models were then adjusted for potential confounding.
Overall, influenza vaccination rate was lower than the Healthy People 2020 target (42.2% vs. 80%). The prevalence of receiving influenza vaccination was higher among adults 65 years and older compared to adults 64 years and younger after adjusting for gender, annual household income, education, marital status, insurance status, and race/ethnicity. Similarly, the prevalence of receiving influenza vaccination was higher among adults who have current asthma, or have ever been diagnosed with diabetes, high blood pressure, cancer (excluding skin), and COPD compared to those who did not have these health conditions, as well as pregnant women compared to women who were not pregnant.
Although high risk groups have higher rates of influenza vaccination compared to low risk groups, more concerted efforts are needed to improve seasonal influenza vaccination in Kansas.
根据疾病控制与预防中心的数据，每年约有5%-20%的人受到流感影响，流感每年导致超过20万例住院病例。本研究的目的是估计堪萨斯州高危成年人中流感疫苗接种的流行率。
分析2013年堪萨斯州行为风险因素监测系统（BRFSS）数据（n = 20,712），以评估堪萨斯州成年人在过去12个月内总体以及特定人口统计学特征人群中接受流感疫苗接种的流行率。使用单变量逻辑回归模型计算粗患病率和调整患病率比值比，以流感疫苗接种作为因变量，健康状况或高危组作为主要自变量；然后对这些模型进行潜在混杂因素调整。
总体而言，流感疫苗接种率低于《健康人民2020》目标（42.2%对80%）。在调整性别、家庭年收入、教育程度、婚姻状况、保险状况和种族/民族后，65岁及以上成年人的流感疫苗接种流行率高于64岁及以下成年人。同样，与没有这些健康状况的成年人相比，目前患有哮喘、或曾被诊断患有糖尿病、高血压、癌症（不包括皮肤癌）和慢性阻塞性肺疾病（COPD）的成年人以及与未怀孕的女性相比孕妇的流感疫苗接种流行率更高。
尽管高危组的流感疫苗接种率高于低危组，但仍需要更协调一致的努力来提高堪萨斯州的季节性流感疫苗接种率。
